What does Seaport Therapeutics, Inc. do?
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs…
What is Seaport Therapeutics, Inc.'s P/E and P/B ratio?
Seaport Therapeutics, Inc. has a P/E ratio of -3.6 and a P/B ratio of -9.61.
What is Seaport Therapeutics, Inc.'s debt-to-equity ratio?
Seaport Therapeutics, Inc. has a debt-to-equity ratio of 0.01.
How much does Seaport Therapeutics, Inc. owe compared with what it owns?
Seaport Therapeutics, Inc. owes $1.51 for every $1 it owns (balance sheet Mar 2026), which means it owes more than it owns.
What is Seaport Therapeutics, Inc.'s Positivity rank?
Seaport Therapeutics, Inc. is ranked #6,526 of 6,774 companies globally and #3,774 of 4,000 in United States on PositoAI, with a Positivity Score of -23,073.
Does Seaport Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Seaport Therapeutics, Inc..
Where can I read the latest news about Seaport Therapeutics, Inc.?
Recent headlines about Seaport Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Seaport Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Seaport Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.